Spatially resolved immune exhaustion within the alloreactive microenvironment predicts liver transplant rejection.

Barbetta, Arianna; Rocque, Brittany; Bangerth, Sarah; Street, Kelly; Weaver, Carly; Chopra, Shefali; Kim, Janet; Sher, Linda et al. · Sci Adv · 2024

Where this comes from

Abstract

Allograft rejection is common following clinical organ transplantation, but defining specific immune subsets mediating alloimmunity has been elusive. Calcineurin inhibitor dose escalation, corticosteroids, and/or lymphocyte depleting antibodies have remained the primary options for treatment of clinical rejection episodes. Here, we developed a highly multiplexed imaging mass cytometry panel to study the immune response in archival biopsies from 79 liver transplant (LT) recipients with either no rejection (NR), acute T cell-mediated rejection (TCMR), or chronic rejection (CR). This approach generated a spatially resolved proteomic atlas of 461,816 cells (42 phenotypes) derived from 96 pathologist-selected regions of interest. Our analysis revealed that regulatory (HLADR<sup>+</sup> T<sub>reg</sub>) and PD1<sup>+</sup> T cell phenotypes (CD4<sup>+</sup> and CD8<sup>+</sup> subsets), combined with variations in M2 macrophage polarization, were a unique signature of active TCMR. These data provide insights into the alloimmune microenvironment in clinical LT, including identification of potential targets for focused immunotherapy during rejection episodes and suggestion of a substantial role for immune exhaustion in TCMR.

Medical subject headings